Categories Earnings, Technology

Ciena stock rises on upbeat Q4 results

Ciena Corporation (CIEN) reported a 95% plunge in earnings for the fourth quarter due to a decline in income tax benefit. However, the results exceeded analysts’ expectations. The top line increased 21% helped by the continued execution of its proven strategy. Following this, the stock inched up over 6% in the premarket session.

Net income plunged 94.5% to $64.98 million and earnings dipped 95% to $0.34 per share. Adjusted earnings soared 66% to $0.53 per share.

Revenue grew 20.8% to $899.4 million, driven by growths across all of its segments. The top line was benefited by the three 10%-plus customers that represented a total of 33.1% of revenue.

Segment-wise, revenue from total networking platforms increased 19% helped by a jump in converged packet optical revenue. Revenue from software and software-related services jumped 61% on an increase in platform software and services revenue and higher blue planet automation software and services revenue. Total global services revenue grew 15%.

25 operators will roll out 5G in 2019: Report

The results were impacted by several mega trends including cloud, mobility and 5G, fiber densification, data center, and IoT & connected objects. This is driven by an increased need for greater bandwidth and adaptive automation.

Looking ahead into the long term, the company said its strategy execution will drive top-line growth, profitability and cash generation. The company expects revenue to be about 6% to 8% annual growth over the next three years and adjusted EPS to be over 20% annual growth per year over the next three years. Free cash flow is predicted to be about 60% to 70% of adjusted operating income in each of the next three years.

Shares of Ciena ended Wednesday’s regular session up 1.74% at $32.14 on the NYSE. The stock has risen over 53% in the year so far and over 48% in the past year.

 

We’re on Apple News! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top